MASTERCLASS Photo: Turm by Stephan Balkenhol - A Sculpture for Wolfsberg Photographer: Ralph Feiner, Architekturfotografie, Malans 6 TH ESO-EONS MASTERCLASS IN ONCOLOGY NURSING 16-21 March 2013 Ermatingen (Lake Constance) Switzerland Chairs: A. Margulies, CH L. Sharp, SE Scientific Co-ordinator: S. Faithfull, UK
The Masterclass in Oncology Nursing programme is designed for advanced oncology nurses as a multi-professional joint event. Five intensive days of full immersion in up-todate oncology will create a collective spirit of teaching and learning to improving clinical skills and patient care. Nursing sessions are specific nursing-oriented sessions exploring specialist practice skills such as advanced assessment, decision making, communication skills, complex symptom management, care of the older patient, psychosocial consequences of cancer therapy. Other sessions will provide the forum for reviewing and understanding the growing evidence base for nursing interventions and reflect on participant s role in clinical leadership. In joint Clinical sessions, nurses will, together with physicians, update their clinical knowledge about the latest issues for the management of various cancers, with an international faculty of experts. Special joint sessions on pain control, survivorship, new oncological emergencies and oral cancer therapies will be supported by workshops and coaching to explore nursing practice in these speciality areas. Practical training will be offered in smaller group optional sessions and coaching groups focusing on skills required for the management of active therapy and follow up. AIMS AND OBJECTIVES The Masterclass aims to prepare oncology nurses for future senior roles and enhance their clinical knowledge in the management of the cancer patient during all phases of the cancer journey. Following completion of the course nurses will be able to use evidence based knowledge in effective symptom management and interventions with the aim to improve patient experience, symptom management and care. Learning outcomes: Understand new developments in oncology disease management. Recognise and describe acute and late adverse effects of cancer and its treatment. Identify complex patient needs across the diagnostic and oncology treatment trajectory. Demonstrate advanced communication skills in managing oncology nursing care. Critically appraise the evidence for cancer symptom management and intervention. Reflect on theoretical underpinnings of decision making. Describe the role of the advanced oncology nurse in leading clinical nursing care. THE MASTERCLASS IS: A 5-day residential educational event Full immersion Clinically-oriented Multidisciplinary An international faculty of top experts delivering advanced concepts ACCREDITATION The Masterclass programme will be accredited by the European Oncology Nursing Society.
TEACHING FORMAT The Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatments with reference to clinical guidelines and which will include notes and resources. Participants will be coached within small groups and discuss personal development plans with tutors in the faculty. Skills based clinical sessions will include simulation and role play and participants must be prepared to join in. All participants will reside at the course venue and participation in the nursing sessions is compulsory throughout the course. The Masterclass will be entirely in English and fluency in English is necessary for admission. Participants of the Masterclass in Nursing Oncology will attend selected medical sessions. Clinical case studies, submitted prior to the course, will be a requirement for all participants. The faculty will evaluate which case studies will be presented for group discussion. FACULTY (as of November 2012) M. Aapro, IMO - Clinique de Genolier, Department of Oncology, Genolier, CH N. Aaronson, Antoni van Leeuwenhoek Hospital, Department of Psychosocial Research & Epidemiology, Amsterdam, NL A. Arber, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK J. Bernier, Genolier Swiss Medical Network, Department of Radiotherapy, Genolier, CH P. Casali, National Cancer Institute, Department of Medical Oncology, Milan, IT A. Cervantes, Hospital Clinico Universitario, Department of Haematology and Medical Oncology, Valencia, ES A. Dietz, University of Leipzig, Department of Otolaryngology, Leipzig, DE S. Faithfull, Faculty of Health and Medical Sciences, University of Surrey, Guilford, UK C. Faivre-Finn, Christie Hospital NHS Foundation Trust, Department of Clinical Oncology, Manchester, UK S.D. Fosså, Univesirsity of Oslo - Institute of Clinical Medicine, Oslo, NO W. Gatzemeier, Humanitas Clinical Institute, Breast Unit, Rozzano, IT N. Harbeck, Uniklinik Köln, Breast Center, Cologne, DE A. Hoy, Consultant in Palliative Medicine, Lead for Advanced Communication Skills SWSH, Epsom, UK C.H. Köhne, Klinikum Oldenburg, Klinik für Onkologie / Hämatologie, Oldenburg, DE P. Lorigan, University of Manchester, Institute of Cancer Sciences, Manchester, UK J.M. Lüthi, Onkologiezentrum Thun-Berner, Thun, CH A. Margulies, Clinical Oncology Nurse, EONS Executive Board Member, Zurich, CH O. Pagani, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH N. Pavlidis, University of Ioannina, Division of Medical Oncology, Ioannina, GR G. Pichert, Cancer geneticist, CH/UK K. Redmond, Cancer World Magazine, Lugano, CH D. Schrijvers, Ziekenhuisnetwerk Antwerpen-Middelheim, Department of Haemato- Oncology, Antwerp, BE D. Sebag-Montefiore, University of Leeds, Leeds Cancer Centre, Department of Clinical Oncology, Leeds, UK C. Sessa, Oncology Institute of Southern Switzerland, Division of Medical Oncology, Bellinzona, CH L. Sharp, Karolinska University Hospital, Section for Nursing, Stockholm, SE R.A. Stahel, University Hospital Zurich, Clinic and Policlinic for Oncology, Zurich, CH E. van Muilekom, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Amsterdam, NL J.B. Vermorken, University Hospital Antwerp, Department of Oncology, Edegem, BE G. Viale, European Institute of Oncology, Department of Pathology, and Milan University, Milan, IT W. Weder, University Hospital Zurich, Division of Thoracic Surgery, Zurich, CH M. Wells, University of Dundee, Dundee, UK
SATURDAY, 16 MARCH PROGRAMME 14:30 Greeting and introduction to Masterclass in Oncology Nursing: Aims and objectives A. Margulies, CH - L. Sharp, SE S. Faithfull, UK 15:00 Group introduction 15:30 Role development: Advanced oncology nursing practice S. Faithfull, UK 16:15 Developing the evidence base for oncology nursing practice 17:00 Overview of Therapy Modalities and new developments in the treatment of prostate cancer L. Sharp, SE E. van Muilekom, NL 17:50 Coffee break 18:20 Group activity - Coaching A. Margulies, CH - L. Sharp, SE S. Faithfull, UK 20:30 Dinner SUNDAY, 17 MARCH 8:30 Clinical session Gastro-intestinal tumours I Chair: D. Sebag-Montefiore, UK Colon cancer: Adjuvant and neoadjuvant treatment of colorectal cancer Systemic treatment in advanced disease A. Cervantes, ES C.H. Köhne, DE 10:00 Coffee break 10:30 Clinical session Gastro-intestinal tumours II Chair: A. Cervantes, ES Management of rectal cancer (surgery and radiotherapy) Systemic treatment in early and advanced gastric cancer D. Sebag-Montefiore, UK A. Cervantes, ES 12:00 Case Studies 1 - Presentation and discussion L. Sharp, SE
13:00 Sponsored lecture Management of senior adults with prostate cancer (SPCC lecture by Sanofi) M. Aapro, CH 13:30 Lunch 14:30 Advanced nursing assessment skills S. Faithfull, UK 15:15 Supportive care Cancer and pregnancy Physical activity for cancer patients N. Pavlidis, GR J.M. Lüthi, CH 16:05 Coffee break 16:30 New developments in radiotherapy S. Faithfull, UK 17:30 Targeted therapy - An introduction A. Margulies. CH 18:30 Sponsored lecture Slot 3 19:30 Dinner MONDAY, 18 MARCH 8:30 Clinical session Breast cancer I Chair: G. Viale, IT What the clinician needs to know about breast pathology (Neo)Adjuvant chemotherapy and biological agents (Neo)Adjuvant endocrine therapy Current controversies and challenges in breast surgery G. Viale, IT N. Harbeck, DE O. Pagani, CH W. Gatzemeier, IT 10:15 Coffee break 10:45 Clinical session Breast cancer II Chair: G. Viale, IT Management of HER-2+ and triple negative advanced breast cancer Management of ER+ advanced breast cancer N. Harbeck, DE O. Pagani, CH 11:45 Case Studies 2 - Presentation and discussion L. Sharp, SE 13:15 Lunch 14:30 Spotlight session 3 Advances in systemic treatment of melanoma P. Lorigan, UK
15:15 Nurse detectives: Who benefits from genetic counselling? G. Pichert, CH/UK 16:00 Research in clinical nursing M. Wells, UK 16:45 Coffee break 17:15 Introduction to Communication Skills A. Hoy, UK - A. Arber, UK 18:15 Spotlight session 6 Cancer of unknown primary N. Pavlidis, GR 19:30 Dinner TUESDAY, 19 MARCH 8:30 Communication skills (Group 1) A. Hoy, UK - A. Arber, UK 8:30 Clinical session Gynaecological cancers Chair: J.B. Vermorken, BE Ovarian cancer Cervical and endometrial cancers J.B. Vermorken, BE C. Sessa, CH 10:30 Coffee break 11:00 Communication skills (Group 2) A. Hoy, UK - A. Arber, UK 11:00 Clinical session Head and neck cancer Chair: J. Bernier, CH Prognostic factors and surgical approach Radiotherapy Systemic therapy A. Dietz, DE J. Bernier, CH J.B. Vermorken, BE 13:00 Lunch 14:30 Market place 16:00 Free time 19:00 Special evening WEDNESDAY, 20 MARCH 8:30 Clinical session Lung cancer and mesothelioma I Chair: R.A. Stahel, CH Surgery Radiotherapy NSCLC systemic therapy W. Weder, CH C. Faivre-Finn, UK R.A. Stahel, CH 10:30 Coffee break
11:00 Clinical session Lung cancer and mesothelioma II Chair: R.A. Stahel, CH Small cell lung cancer C. Faivre-Finn, UK 12:00 Case Studies 3 - Presentation and discussion L. Sharp, SE 13:00 Lunch 14:30 Putting Evidence into Practice - guideline development - an EONS/EPAAC/ONS initiative A. Margulies, CH 15:30 Patient safety and team communication L. Sharp, SE 16:30 Coffee break 17:00 Learning assessment test 18:00 "Pictures speak louder than words" GROUP WORK - CLOSURE 19:30 Dinner THURSDAY, 21 MARCH 8:30 Spotlight session 7 Rare cancers P. Casali, IT 9:30 JOINT medics and nursing session I Pain control acute/chronic/breakthrough Suvivorship and frequent (patient relevant) late side effects from all treatment modalities D. Schrijvers, BE N. Aaronson, NL 10:30 Coffee break 11:00 JOINT medics and nursing session II New oncological emergencies - new problems arising with the newer drugs Facilitating patient adherence to oral cancer therapies S.D. Fosså, NO K. Redmond, CH 12:00 Close
GENERAL INFORMATION PROFILE OF THE IDEAL CANDIDATE Nurse with a masters degree (obtained in the past 5 years) in nursing / oncology nursing or equivalent in the country of residence; Is working at an advanced nursing practice level, and has had at least 2-3 years of clinical oncology nursing practice; Is involved in direct patient care, cancer nursing research, cancer nursing education (postgraduate and master level), or the management, organisation and co-ordination of cancer patient care; Is fluent in English (reading and speaking); Is a member of an EONS member society or is an individual member. ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLY Successful applicants are granted free registration and accommodation APPLICATION DEADLINE: 1 ST DECEMBER 2012 HOW TO APPLY Complete Application Form (available at www.cancernurse.eu or on request to eons.secretariat@cancernurse.eu ) A short curriculum vitae including topic of master s thesis (or similar) and details of further post registration training Provide a short letter (max. 200 words) about motivation for attending Supporting letter from head of department or mentor Provide an abstract of 300 words on advanced nursing practice: my experience and practice Only applications with all required attachments will be considered. FOR FURTHER INFORMATION: eons.secretariat@cancernurse.eu European Oncology Nursing Society, EONS Secretariat Att. Rudi Brike E. Mounierlaan 83 1200 Brussels, Belgium Phone +32 2 779 9923, Fax +32 2 779 9937 Further information is also available at www.eso.net is member of